Elevance Health Inc
For the period ended Dec 31, 2023. Filed Feb 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 21, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ELEVANCE HEALTH, INC. | |
|---|---|
| By: | /s/ GAIL K. BOUDREAUX |
| Gail K. BoudreauxPresident and Chief Executive Officer | |
Dated: February 21, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ GAIL K. BOUDREAUX | President and Chief Executive Officer, Director(Principal Executive Officer) | February 21, 2024 |
| Gail K. Boudreaux | ||
| /s/ MARK B. KAYE | Executive Vice President and Chief Financial Officer (Principal Financial Officer) | February 21, 2024 |
| Mark B. Kaye | ||
| /s/ RONALD W. PENCZEK | Chief Accounting Officer and Controller (Principal Accounting Officer) | February 21, 2024 |
| Ronald W. Penczek | ||
| /s/ ELIZABETH E. TALLETT | Chair of the Board | February 21, 2024 |
| Elizabeth E. Tallett | ||
| /s/ R. KERRY CLARK | Director | February 21, 2024 |
| R. Kerry Clark | ||
| /s/ SUSAN D. DEVORE | Director | February 21, 2024 |
| Susan D. DeVore | ||
| /s/ ROBERT L. DIXON, JR. | Director | February 21, 2024 |
| Robert L. Dixon, Jr. | ||
| /s/ LEWIS HAY III | Director | February 21, 2024 |
| Lewis Hay III | ||
| /s/ BAHIJA JALLAL | Director | February 21, 2024 |
| Bahija Jallal | ||
| /s/ ANTONIO F. NERI | Director | February 21, 2024 |
| Antonio F. Neri | ||
| /s/ RAMIRO G. PERU | Director | February 21, 2024 |
| Ramiro G. Peru | ||
| /s/ RYAN M. SCHNEIDER | Director | February 21, 2024 |
| Ryan M. Schneider | ||
| /s/ DEANNA D. STRABLE | Director | February 21, 2024 |
| Deanna D. Strable | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.